ARRB2 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon4.
ARB 2, ARR 2, ARRB2_HUMAN, Arrestin 3, Arrestin beta-2, BARR2, Beta-arrestin-2, DKFZp686L0365, HGNC:712
ARRB2 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon4.
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.
Beta-arrestin 2 also known as arrb2 or b-arrestin mechanically functions to regulate G protein-coupled receptor (GPCR) signaling. This protein has a molecular mass of approximately 47 kDa and is ubiquitously expressed across various tissues including the brain lungs and heart. Beta-arrestin 2 works by binding to phosphorylated GPCRs facilitating receptor desensitization and endocytosis which stops the receptor's signaling activity and mediates receptor internalization.
Beta-arrestin 2 plays an important role in mediating signal transduction pathways beyond GPCR desensitization including those involved in cell communication and cellular response regulation. Beta-arrestin 2 interacts with multiple signaling proteins to form complexes that facilitate signaling pathways notably influencing MAPK (Mitogen-Activated Protein Kinase) pathways. It provides a scaffold for downstream signaling molecules affecting cell signaling outcomes.
Beta-arrestin 2 significantly participates in two important biological pathways: the MAPK pathway and the Wnt signaling pathway. Through these pathways beta-arrestin 2 interacts with signaling proteins such as ERK1/2 (Extracellular signal-Regulated Kinases) and dishevelled proteins. These interactions highlight beta-arrestin 2's ability to modulate signal strength and duration contributing to diverse cellular responses.
Beta-arrestin 2 is implicated in conditions like heart failure and certain cancers. The aberrant regulation of beta-arrestin 2-related pathways can lead to uncontrolled cell proliferation or inadequate heart responses. Additionally beta-arrestin 2 is connected to proteins like GPCR kinases in the context of heart failure and MAPK proteins within oncogenic processes underlining its potential as a therapeutic target.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Lanes 1 - 4: Merged signal (red and green). Green - Anti-Beta Arrestin 2 antibody [3G1] ab54790 observed at 50 kDa. Red - loading control Anti-GAPDH antibody [EPR16891] - Loading Control ab181602 (Rabbit Anti-GAPDH antibody [EPR16891]) observed at 37 kDa.
Anti-Beta Arrestin 2 antibody [3G1] ab54790 was shown to react with Beta Arrestin 2 in wild-type HepG2 cells in Western blot with loss of signal observed in ARRB2 knockout cell line Human ARRB2 (Beta Arrestin 2) knockout Hep G2 cell line ab262320 (knockout cell lysate ab257283). Wild-type HepG2 and ARRB2 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with Anti-Beta Arrestin 2 antibody [3G1] ab54790 and Anti-GAPDH antibody [EPR16891] - Loading Control ab181602 (Rabbit Anti-GAPDH antibody [EPR16891]) overnight at 4 °C at 1 μg/ml and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed (Goat anti-Mouse IgG H&L (IRDye® 800CW) preadsorbed ab216772) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed (Goat Anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed ab216777) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.
All lanes: Western blot - Anti-Beta Arrestin 2 antibody [3G1] (Anti-Beta Arrestin 2 antibody [3G1] ab54790) at 1 µg/mL
Lane 1: Wild-type HepG2 cell lysate at 20 µg
Lane 2: ARRB2 knockout HepG2 cell lysate at 20 µg
Lane 2: Western blot - Human ARRB2 (Beta Arrestin 2) knockout Hep G2 cell line (Human ARRB2 (Beta Arrestin 2) knockout Hep G2 cell line ab262320)
Lane 3: HeLa cell lysate at 20 µg
Lane 4: Human Lung tissue lysate at 20 µg
Performed under reducing conditions.
Predicted band size: 46 kDa
Observed band size: 50 kDa
Lane 1: Wild-type HepG2 cell lysate (20µg)
Lane 2: ARRB2 knockout HepG2 cell lysate (20µg)
Lane 3: A549 cell lysate (20µg)
Lane 4: K562 cell lysate (20µg)
Lanes 1- 4: Merged signal (red and green). Green - Anti-Beta Arrestin 2 antibody [3G1] ab54790 observed at 55 kDa. Red - loading control Anti-GAPDH antibody [EPR16891] - Loading Control ab181602 observed at 37 kDa.
Anti-Beta Arrestin 2 antibody [3G1] ab54790 Anti-Beta Arrestin 2 antibody was shown to specifically react with ARRB2 in wild-type HepG2 cells in western blot. Loss of signal was observed when knockout cell line Human ARRB2 (Beta Arrestin 2) knockout Hep G2 cell line ab262320 (knockout cell lysate ab257283) was used. Wild-type and ARRB2 knockout samples were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. Anti-Beta Arrestin 2 antibody [3G1] ab54790 and Anti-GAPDH antibody[EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) were incubated overnight at 4°C at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Mouse IgG H&L (IRDye® 800CW) preadsorbed (Goat anti-Mouse IgG H&L (IRDye® 800CW) preadsorbed ab216772) and Goat Anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (Goat Anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed ab216777) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes: Western blot - Anti-Beta Arrestin 2 antibody [3G1] (Anti-Beta Arrestin 2 antibody [3G1] ab54790) at 1/500 dilution
Lane 1: Wild-type HepG2 cell lysate at 20 µg
Lane 2: ARRB2 knockout HepG2 cell lysate at 20 µg
Lane 2: Western blot - Human ARRB2 (Beta Arrestin 2) knockout Hep G2 cell line (Human ARRB2 (Beta Arrestin 2) knockout Hep G2 cell line ab262320)
Lane 3: A549 cell lysate at 20 µg
Lane 4: K562 cell lysate at 20 µg
Performed under reducing conditions.
Predicted band size: 46 kDa
Observed band size: 55 kDa
Homozygous: 1 bp deletion in exon4
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com